1. Home >
  2. Investors >
  3. Private Equity Firm >
  4. United States >
  5. New York >
  6. OrbiMed Advisors >
  7. M&A

OrbiMed Advisors Mergers & Acquisitions

OrbiMed Advisors M&A Summary

The Firm’s most common exit type is ipo (50%). OrbiMed Advisors’ largest (disclosed) exit occurred in 2018 when it sold GENEWIZ for $450M.

Sign-up to view OrbiMed Advisors’ full profile and discover more large private equity firm investors just like it.

M&A Summary

  • M&A Total Activity9
    • M&A Buy Activity5
    • M&A Sell Activity4
  • M&A Buy/Sell Connections6

OrbiMed Advisors LLC

601 Lexington Avenue, 54th Floor,
New York, New York 10022
United States
(212) 739-6400
www.orbimed.com
info@orbimed.com

All (9) Buy (5) Sell (4)
Date Target Value
$mlns 		Transaction Type Acquirer Seller SRC
Link
2020-01-30 Arcutis · Life Science
Westlake Village, California · www.arcutis.com

Arcutis is focused on developing topical medicines for the treatment of skin diseases. The company’s lead program, ARQ-151, is a topical formulation of roflumilast that is currently in Phase 2 studies for the treatment of plaque psoriasis and atopic dermatitis. The company’s second program, ARQ-250, is a topical JAK1-inhibitor in preclinical development for the treatment of various autoimmune diseases affecting the skin. Arcutis was founded in 2016 and is based in Westlake Village, California.

- IPO -

Frazier Healthcare Partners PE

HBM Partners PE

OrbiMed Advisors LLC PE


Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Try Free

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Mergr

Solution for

Product

Company

Legal